About Us

Group Respite

Relatives as Parents

Leadership in Aging





The Brookdale Foundation Group


Frank W. Burr Blvd

Suite 13

Teaneck, NJ









Roy N. Alcalay, MD, MSc

R. AlcalayDr. Alcalay is an Assistant Professor in the Department of Neurology at Columbia University Medical Center in New York City.  He received his BSc and his MD from Tel- Aviv University, Israel.  He completed internship training at Massachusetts General Hospital, and neurology residency training at Massachusetts General Hospital / Brigham and Women’s Hospital in Boston. After residency he pursued clinical fellowship training at the Columbia University Center for Parkinson’s Disease and Other Movement Disorders Center. During his fellowship he also completed a master’s in biostatistics, patient oriented research track, at the Irving Institute for Clinical and Translational Research, Columbia’s Clinical and Translational Science Award (CTSA). During his fellowship he participated in an ongoing research study focusing on the genetic risk factors for Parkinson’s disease, the Consortium Of Risk for Early Onset Parkinson Disease (CORE-PD). In addition to his training in movement disorders he has developed expertise in the evaluation of dementia.

Dr. Alcalay’s research focuses on the genetic risk factors for parkinsonism associated with cognitive impairment. As a Brookdale fellow Dr. Alcalay will assess whether carrying specific genetic mutations [in the glucocerebrosidase (GBA) gene] predisposes Parkinson’s patients to develop cognitive impairment. He will also explore a biochemical marker of Parkinson disease. Lastly, because the impact of genetic testing for the elderly in terms of their knowledge and interest in obtaining genetic information is largely unknown, Dr. Alcalay will assess attitudes towards genetic testing in the Parkinson’s population he is studying. Upon completion of this research Dr. Alcalay endeavors to broaden the understanding of the association between genetic factors and Parkinson’s disease; specifically, how genetic profiling may help caregivers predict disease progression, and patients’ perception and understanding of this information. These studies in Parkinson’s disease may serve as the foundation for similar research in other neurodegenerative disorders.

Dr. Alcalay’s primary mentor is Karen S. Marder, MD, MPH and his secondary mentor is Wendy K. Chung, MD, PhD.

Brookdale Leadership in Aging Fellow Class of 2010

Last updated 4/10